Last quarter (Q3 2023), 2seventy bio's total revenue was $12.03M, a decrease of -10.25% from the same quarter last year. In Q3, 2seventy bio's net income was $-71.64M. See 2seventy bio’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 70.43M	$ 55.49M	$ 21.38M	$ 248.12M	$ 44.30M
Cost of Revenue	$ 5.28M	$ -1.73M	$ -2.52M	$ 5.40M	$ 2.98M
Gross Profit	$ 56.07M	$ 32.92M	$ 15.01M	$ 242.73M	$ 41.32M
Operating Expense	$ 300.77M	$ 328.19M	$ 355.44M	$ 387.36M	$ 379.29M
Operating Income	$ -269.83M	$ -295.27M	$ -340.43M	$ -144.64M	$ -337.97M
Net Non Operating Interest Income Expense	$ 10.26M	$ 2.93M	$ 88.00K	$ 0.00	$ 0.00
Other Income Expense	$ -88.69M	$ -38.18M	$ -48.13M	$ 24.52M	$ 17.38M
Pretax Income	$ -183.91M	$ -254.15M	$ -292.21M	$ -120.11M	$ -320.59M
Tax Provision	$ -17.00K	-	-	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-
Net Income Common Stockholders	$ -183.89M	$ -254.15M	$ -292.21M	$ -120.11M	$ -320.59M
Basic EPS	$ -3.46	$ -7.13	$ -12.44	$ -5.16	$ -13.77
Diluted EPS	$ -3.46	$ -7.13	$ -12.44	$ -5.16	$ -13.77
Basic Average Shares	$ 181.25M	$ 35.64M	$ 23.50M	$ 23.29M	$ 23.29M
Diluted Average Shares	$ 181.25M	$ 35.64M	$ 23.50M	$ 23.29M	$ 23.29M
Dividend Per Share	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-
Total Expenses	$ 306.05M	$ 326.46M	$ 352.93M	$ 392.76M	$ 382.27M
Net Income From Continuing And Discontinued Operation	$ -183.89M	$ -254.15M	$ -292.21M	$ -120.11M	$ -320.59M
Normalized Income	$ -69.07M	-	-	$ -126.58M	$ -317.85M
Interest Expense	-	-	-	$ 0.00	$ 0.00
EBIT	$ -185.40M	$ -254.15M	$ -292.21M	$ -144.64M	$ -320.59M
EBITDA	$ -175.82M	$ -242.62M	$ -275.86M	$ -131.45M	$ -308.01M

Currency in USD

2seventy bio Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing